Pharma Pulse 12/3/24: Shaping the Future of Commercialization, Looming PREP Act Expiration Could Impact Rural Patients & more

Shaping the Future of Commercialization

Chase Feiger, MD, co-founder, Ostro, outlines the trends he expects to see over the next 10-15 years when it comes to the intersection of AI and life sciences.

Looming PREP Act Expiration Could Impact Health Care Access for Rural Patients

The Act is set to end at the end of 2024, which will affect pharmacists’ abilities to administer COVID-19 tests, vaccines, and treatment that are distributed by the federal government.

Major Canadian News Outlets Sue OpenAI in New Copyright Case

A coalition of some of Canada’s biggest media companies is seeking billions of dollars in compensation for what they say is copyright infringement on their work through ChatGPT.

New Biovanta Study Shows Best Efficacy in Treating Common Cold

Common cold viruses contribute significantly to lost productivity and overall well-being, amounting to nearly $40 billion in annual productivity losses. Treatment with Biovanta could significantly lessen that impact, according to a paper published in the peer-reviewed journal PLOS ONE. The study presents findings from a large, multi-center, placebo-controlled clinical trial involving 157 participants with cold symptoms in six cities across the United States.

AbelsonTaylor Group on LinkedIn

We kicked off the holidays with gratitude for our talented teams and the well-deserved recognition by Pharmaceutical Executive in their coverage of AT Group's four Apex Award wins!

https://lnkd.in/gE3b26Pq

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs